As PC is regularly diagnosed at advanced clinical stages, with over 50% of patients presenting with metastatic disease,1 we evaluated whether CaSm overexpression, which is believed to occur early in neoplastic progression, contributes to cellular migration and invasion. Here, LSM1 is linked to pachyonychia congenita.